The trial to reach, what is expected to be a bellwether verdict, in the first of the four Xarelto federal litigation cases, which were identified earlier in August, 2016, is imminent. According to an article in LawyersandSettlements.com, the trial is scheduled for March, 2017 in Louisiana and involves a plaintiff who first used Xarelto in January, 2014 to treat his condition of atrial fibrillation (irregular heartbeat). The plaintiff claimed in his lawsuit that he had to be hospitalized for internal bleeding and received multiple blood transfusions. The decision in this Xarelto lawsuit could send shockwaves throughout the courts, as many wait to see if a verdict is found in the plaintiff’s favor.
What Are Bellwether Cases?
This initial set of cases that are now being brought to trial is considered a good representation of the overall mass tort and the subsequent verdicts are expected to serve as a predictor of the general worth of specific injuries in future Xarelto trials. When a judge chooses to use bellwether trials, the judge and the parties normally select an illustrative tester of cases, usually five to ten, which will be wholly prepared and tried before a jury. The goal of a bellwether case process is to give all involved parties an indication of what is likely to happen in future trials and to advance the litigation in a timely manner.
The next three cases have also been scheduled for trial in the months of April and May this year. The plaintiff in the second case that is set for trial, also in Louisiana. The plaintiff’s wife died after using Xarelto for a month and suffering a cerebral hemorrhage (bleeding in the brain), based on the lawsuit. The third trial will be in Mississippi and involves another plaintiff who was prescribed Xarelto for the treatment of her blood clots. She alleges that the drug caused gastrointestinal bleeding and led to her injuries. The fourth trial will decide the case of William Henry. The victim here had taken Xarelto for atrial fibrillation and died subsequently due to gastrointestinal bleeding.
Why Is Xarelto A Dangerous Drug?
Xarelto is manufactured by Bayer and marketed by Janssen Pharmaceuticals – a subsidiary of Johnson and Johnson. Victims have stated that the use of Xarelto led to severe bleeding and that Bayer did not warn them sufficiently about the bleeding risks involved with the drug or let them know about the unavailability (at the time) of a reversing agent that could be used to counter or stem the bleeding.
The research website, HealthGrove.com has ranked Xarelto 24th in their list of the 50 most dangerous prescription drugs that are available in the nation. The list was compiled based on the highest number of adverse reactions of a drug and ranked by the percentage of serious reactions. Currently, the number of MDL cases that have been filed against Bayer and Johnson and Johnson for their defective drug Xarelto is estimated to be nearly 14,000.
Contact a Xarelto Lawyer
If you or a loved one has suffered from serious side effects from Xarelto, you should talk to an experienced lawyer about your legal options. You may be entitled to compensation for medical expenses, lost income, pain and suffering, or other losses. We are working with some of the more experienced Xarelto Lawyers, who handle these cases. There is no legal fee unless you receive a settlement or award. Feel free to call us toll-free at 1-800-992-6878 or submit a contact form online for a free (no obligation) case evaluation.